The effect of topical bevacizumab on corneal neovascularization.

PURPOSE To examine the effect of topical bevacizumab on corneal neovascularization (NV) over a period of 3 months. DESIGN Prospective, nonrandomized, masked observational case series. PARTICIPANTS Ten eyes of 7 patients with corneal NV. METHODS Patients received topical bevacizumab (1.25%) twice daily. Ophthalmic evaluations included visual acuity… CONTINUE READING